SARS-CoV-2 and the Pandemic Surge in Invasive Group A Streptococcal Disease
This population-based study in Ontario suggests that the post-pandemic surge in invasive Group A Streptococcal disease is primarily driven by cumulative SARS-CoV-2 exposure and associated immune dysregulation rather than an "immunity debt" caused by reduced pathogen exposure.